ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Boehringer Ingelheim at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Boehringer Ingelheim brings 5 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2221. Its program centres on interstitial lung disease and progressive pulmonary fibrosis in autoimmune disease, covering diagnosis, treatment, economic burden and the T-cell effects of a PDE4B inhibitor.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Boehringer Ingelheim Ridgefield, CT | |
A global pharmaceutical company with medicines and research programs across human and animal health. | Booth Exhibiting at Booth 2221 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Industry Sun Nov 8 2:30pm–3:15pm Make Rheum for Lungs: Treating Progressive Pulmonary Fibrosis in Your Patients Industry Sun Nov 8 5:30pm–7:30pm Suspect. Detect. Act: Diagnosing and Treating Autoimmune Interstitial Lung Disease Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at Boehringer Ingelheim
Tell us what you sell and we’ll find the people at Boehringer Ingelheim most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction